Komori
Zuiko (6279) · InitiativeUpdated for R&D expenses for the interim consolidated accounting period

Continuation of Research and Development Activities

First written in FY2017-Q1. 28 of 34 entries say "Restated". Latest entry: FY2027-H1.

34entries
11years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2017-Q1 – FY2020-Q3RestatedFY2022-Q1 – FY2023-Q3RestatedFY2024-Q1 – FY2027-H12016: 320162017: 420172018: 320182019: 420192020: 420202021: 420212022: 320222023: 420232024: 320242025: 120252026: 12026
Same theme, other companies
Continuation of R&D activities with no change in statusA theme 192 companies write about · 0 as a headwind · 181 as a tailwind

45 other companies' latest entry also says "Other".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 192 companies compared. The sentences above are computed from all 192.
Full recordFilings, disclosures and news, newest first
  1. FY2027-H1Updated for R&D expenses for the interim consolidated accounting periodAnnual report

    「The amount of research and development activities for the entire Group during the current interim consolidated accounting period was ¥111 million.」

    Research and development expenses for the interim consolidated accounting period totaled ¥111 million. It is stated that there were no material changes in the status of research and development activities.
  2. FY2026-H1Updated for R&D expenses for the interim consolidated accounting periodAnnual report

    「The amount of research and development activities for the entire Group during the current interim consolidated accounting period was ¥71 million.」

    Research and development expenses for the interim consolidated accounting period totaled ¥71 million. It is stated that there were no material changes in the status of research and development activities.
  3. FY2025-H1RestatedAnnual report

    「The amount of research and development activities for the entire Group during the current interim consolidated accounting period was ¥77 million. There were no material changes in the status of the Group's research and development activities during the current interim consolidated accounting period.」

    Research and development expenses for the interim consolidated accounting period totaled ¥77 million, and it has been reconfirmed that there were no material changes in the status of research and development activities.
  4. FY2025-Q1RestatedAnnual report

    「The amount of research and development activities for the entire Group during the first three months of the current consolidated fiscal year was ¥31 million. There were no material changes in the status of the Group's research and development activities during the first three months of the current consolidated fiscal year.」

    Research and development expenses for the first three months totaled ¥31 million, and it has been reconfirmed that there were no material changes in the status of research and development activities.
  5. FY2024RestatedAnnual report

    「Total research and development expenses for the current consolidated fiscal year were ¥332 million. The main activities were research and development related to new material-processing processes, with a view to developing equipment that takes resource conservation, reduced energy consumption and the use of environmentally friendly materials into consideration for the purpose of enhancing the added value of hygiene material products, and applying the equipment to production facilities.」

    Research and development is continuing, with the main themes being research and development expenses of ¥332 million, equipment development that takes resource conservation, reduced energy consumption and environmentally friendly materials into consideration, and new material-processing processes.
  6. FY2024-Q3RestatedAnnual report

    「The amount of research and development activities for the entire Group during the first nine months of the current consolidated fiscal year was ¥287 million. There were no material changes in the status of the Group's research and development activities during the first nine months of the current consolidated fiscal year.」

    Research and development expenses for the first nine months totaled ¥287 million, and it has been reconfirmed that there were no material changes in the status of research and development activities.
  7. FY2024-Q2RestatedAnnual report

    「The amount of research and development activities for the entire Group during the first six months of the current consolidated fiscal year was ¥252 million. There were no material changes in the status of the Group's research and development activities during the first six months of the current consolidated fiscal year.」

    Research and development expenses for the first six months totaled ¥252 million, and it has been reconfirmed that there were no material changes in the status of research and development activities.
  8. FY2024-Q1RestatedAnnual report

    「The amount of research and development activities for the entire Group during the first three months of the current consolidated fiscal year was ¥150 million. There were no material changes in the status of the Group's research and development activities during the first three months of the current consolidated fiscal year.」

    Research and development expenses for the first three months totaled ¥150 million, and it has been reconfirmed that there were no material changes in the status of research and development activities.
  9. FY2023ReframedAnnual report

    「Total research and development expenses for the current consolidated fiscal year were ¥857 million. The main activities were research and development related to new material-processing processes, with a view to developing equipment that takes resource conservation, reduced energy consumption and resource recycling into consideration for the purpose of enhancing the added value of hygiene material products, and applying the equipment to production facilities.」

    Research and development expenses of ¥857 million were recorded, and the research themes have been expanded beyond conventional high-speed and material-processing processes to include equipment development that takes resource conservation, reduced energy consumption and resource recycling into consideration.
  10. FY2023-Q3RestatedAnnual report

    「The amount of research and development activities for the entire Group during the first nine months of the current consolidated fiscal year was ¥581 million. There were no material changes in the status of the Group's research and development activities during the first nine months of the current consolidated fiscal year.」

    Research and development expenses for the first nine months totaled ¥581 million, and it has been reconfirmed that there were no material changes in the status of research and development activities.
  11. FY2023-Q2RestatedAnnual report

    「The amount of research and development activities for the entire Group during the first six months of the current consolidated fiscal year was ¥330 million. There were no material changes in the status of the Group's research and development activities during the first six months of the current consolidated fiscal year.」

    Research and development expenses for the first six months totaled ¥330 million, and it has been reconfirmed that there were no material changes in the status of research and development activities.
  12. FY2023-Q1RestatedAnnual report

    「The amount of research and development activities for the entire Group during the first three months of the current consolidated fiscal year was ¥154 million. There were no material changes in the status of the Group's research and development activities during the first three months of the current consolidated fiscal year.」

    Research and development expenses for the first three months totaled ¥154 million, and it has been reconfirmed that there were no material changes in the status of research and development activities.
  13. FY2022-Q3RestatedAnnual report

    「The amount of research and development activities for the entire Group during the first nine months of the current consolidated fiscal year was ¥328 million. There were no material changes in the status of the Group's research and development activities during the first nine months of the current consolidated fiscal year.」

    Research and development expenses for the first nine months totaled ¥328 million, and it has been reconfirmed that there were no material changes in the status of research and development activities.
  14. FY2022-Q2RestatedAnnual report

    「The amount of research and development activities for the entire Group during the first six months of the current consolidated fiscal year was ¥214 million. There were no material changes in the status of the Group's research and development activities during the first six months of the current consolidated fiscal year.」

    Research and development expenses for the first six months totaled ¥214 million, but it has been reconfirmed that there were no material changes in the status of research and development activities.
  15. FY2022-Q1RestatedAnnual report

    「The amount of research and development activities for the entire Group during the first three months of the current consolidated fiscal year was ¥101 million. There were no material changes in the status of the Group's research and development activities during the first three months of the current consolidated fiscal year.」

    Research and development expenses for the first three months totaled ¥101 million, and it has been reconfirmed that there were no material changes in the status of research and development activities.
  16. FY2021AdvancedAnnual report

    「The total research and development expenditure for the fiscal year was ¥233 million. The main area was research and development of new, high-speed, high-quality mask manufacturing machinery to enhance the value added of hygiene products amid the spread of COVID-19.」

    Research and development expenditure was ¥233 million, with research and development of new, high-speed, high-quality mask manufacturing machinery identified as the main theme.
  17. FY2021-Q3RestatedAnnual report

    「The Group's total research and development expenditure during the cumulative third quarter was ¥168 million. There were no significant changes in the status of the Group's research and development activities during the cumulative third quarter.」

    Cumulative third-quarter research and development expenditure was ¥168 million, reaffirming that there were no significant changes in the status of the research and development activities.
  18. FY2021-Q2RestatedAnnual report

    「The Group's total research and development expenditure during the cumulative second quarter was ¥129 million. There were no significant changes in the status of the Group's research and development activities during the cumulative second quarter.」

    Cumulative second-quarter research and development expenditure was ¥129 million, reaffirming that there were no significant changes in the status of the research and development activities.
  19. FY2021-Q1RestatedAnnual report

    「The Group's total research and development expenditure during the cumulative first quarter was ¥74 million. There were no significant changes in the status of the Group's research and development activities during the cumulative first quarter.」

    Cumulative first-quarter research and development expenditure was ¥74 million, reaffirming that there were no significant changes in the status of the research and development activities.
  20. FY2020ReframedAnnual report

    「The total research and development expenditure for the fiscal year was ¥131 million. The main areas were development of equipment to enhance the value added of hygiene material products and research and development of new material processing processes for application to production facilities.」

    Research and development expenditure was ¥131 million, with the main themes identified as equipment development to enhance the value added of hygiene material products and research and development of new material processing processes. The amount also changed from ¥159 million in the previous fiscal year.
  21. FY2020-Q3RestatedAnnual report

    「The Group's total research and development expenditure during the cumulative third quarter was ¥82 million. There were no significant changes in the status of the Group's research and development activities during the cumulative third quarter.」

    Cumulative third-quarter research and development expenditure was ¥82 million, reaffirming that there were no significant changes in the status of the research and development activities.
  22. FY2020-Q2RestatedAnnual report

    「The Group's total research and development expenditure during the cumulative second quarter was ¥56 million. There were no significant changes in the status of the Group's research and development activities during the cumulative second quarter.」

    Cumulative second-quarter research and development expenditure was ¥56 million, reaffirming that there were no significant changes in the status of the research and development activities.
  23. FY2020-Q1RestatedAnnual report

    「The Group's total research and development expenditure for the cumulative first quarter was ¥26 million. There were no material changes in the status of the Group's research and development activities during the cumulative first quarter.」

    Cumulative first-quarter research and development expenditure was ¥26 million, reaffirming that there were no significant changes in the status of the research and development activities.
  24. FY2019RestatedAnnual report

    「The Group's basic approach to research and development is to develop proprietary technologies ahead of growing customer and environmental needs. Total research and development expenditure for the fiscal year was ¥159 million. The main areas were development of equipment to accelerate production facilities and research and development of new material processing processes for application to production facilities.」

    Research and development continued, with research and development expenditure of ¥159 million and the main themes identified as proprietary technologies addressing customer and environmental needs, acceleration of production facilities and new material processing processes.
  25. FY2019-Q3RestatedAnnual report

    「The Group's total research and development expenditure during the cumulative third quarter was ¥117 million. There were no significant changes in the status of the Group's research and development activities during the cumulative third quarter.」

    Cumulative third-quarter research and development expenditure was ¥117 million, reaffirming that there were no significant changes in the status of the research and development activities.
  26. FY2019-Q2RestatedAnnual report

    「The Group's total research and development expenditure during the cumulative second quarter was ¥81 million. There were no significant changes in the status of the Group's research and development activities during the cumulative second quarter.」

    Cumulative second-quarter research and development expenditure was ¥81 million, reaffirming that there were no significant changes in the status of the research and development activities.
  27. FY2019-Q1RestatedAnnual report

    「The Group's total research and development expenditure during the cumulative first quarter was ¥44 million. There were no significant changes in the status of the Group's research and development activities during the cumulative first quarter.」

    Cumulative first-quarter research and development expenditure was ¥44 million, reaffirming that there were no significant changes in the status of the research and development activities.
  28. FY2018-Q3RestatedAnnual report

    「The Group's total research and development expenditure during the cumulative third quarter was ¥125 million. There were no significant changes in the status of the Group's research and development activities during the cumulative third quarter.」

    Cumulative third-quarter research and development expenditure was ¥125 million, reaffirming that there were no significant changes in the status of the research and development activities.
  29. FY2018-Q2RestatedAnnual report

    「The Group's total research and development expenditure during the cumulative second quarter was ¥75 million. There were no significant changes in the status of the Group's research and development activities during the cumulative second quarter.」

    Cumulative second-quarter research and development expenditure was ¥75 million, reaffirming that there were no significant changes in the status of the research and development activities.
  30. FY2018-Q1RestatedAnnual report

    「The Group's total research and development expenditure for the cumulative first quarter was ¥26 million. There were no material changes in the status of the Group's research and development activities during the cumulative first quarter.」

    Research and development expenditure was ¥26 million, reaffirming that there were no significant changes in the status of the research and development activities.
  31. FY2017RestatedAnnual report

    「The total research and development expenditure for the fiscal year was ¥104 million. The main areas were research into automation technologies to reduce labor requirements in production equipment operations, development of equipment to accelerate production equipment, and research and development of new material processing processes.」

    Research and development continued, with research and development expenditure of ¥104 million and the main research themes identified as automation, acceleration and new material processing processes.
  32. FY2017-Q3RestatedAnnual report

    「The Group's total research and development expenditure during the cumulative third quarter was ¥96 million. There were no significant changes in the status of the Group's research and development activities during the cumulative third quarter.」

    Cumulative third-quarter research and development expenditure was ¥96 million, and the disclosure states that there were no significant changes in the status of the research and development activities.
  33. FY2017-Q2RestatedAnnual report

    「The Group's total research and development expenditure during the cumulative second quarter was ¥46 million. There were no significant changes in the status of the Group's research and development activities during the cumulative second quarter.」

    Research and development expenditure was ¥46 million, and the disclosure states that there were no significant changes in the status of the activities.
  34. FY2017-Q1First statedAnnual report

    「The Group's total research and development expenditure for the first quarter was ¥10 million. There were no material changes in the status of our Group's research and development activities during the first quarter.」

    Research and development expenditure for the quarter was ¥10 million, and the filing states that there were no material changes in the status of R&D activities.
Moved together

"Deteriorating sales environment due to customer investment plan revisions and the normalization of inbound demand" moved the same way as this thread, in the same document, in 3 of its 34 moves.

322★123
  1. ★This thread
  2. 1Deteriorating sales environment due to customer investment plan revisions and the normalization of inbound demand3×
  3. 2Cost improvement initiatives2×
  4. 3Uncertainty surrounding domestic and overseas economic conditions, foreign exchange rates and resource prices2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Zuiko yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Continuation of Research and Development Activities | ZUIKO CORPORATION (6279) | Komori